RecruitingNCT04964310

Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control Study

Studying Paracetamol poisoning

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: The First Affiliated Hospital with Nanjing Medical University
Principal Investigator: Jingsong Zhang, professor
The First Affiliated Hospital with Nanjing Medical University
Intervention: genetic polymorphism(genetic)
Enrollment: 339 enrolled
Eligibility: 14 years · All sexes
Timeline: 2020 – 2026

Study locations (1)

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

Collaborators

University of Colorado, Denver · Beijing Genomics Institute · Nanjing Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04964310 on ClinicalTrials.gov

Other trials for Paracetamol poisoning

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06549062
Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.
University Hospital, Ghent

See all trials for Paracetamol poisoning →

← Back to all trials